H.I.G. Capital related stories
All articles and analysis
H.I.G. Capital on the mid-market mentalitySpecialist underwriting and a focus on the mid-market are shaping the next phase of secondaries’ development, say Dan Wieder and Yash Gupta, managing directors at H.I.G. Capital.
Side Letter: Gating-gateIn today's edition, Blue Owl's recent asset sale has thrust semi-liquids into the spotlight; Partners Group tries to assuage investors' AI concerns; Gridiron Capital is back in the market.
Distribution and liquidity strains supercharge secondaries: Story of the YearVolatility, new entrants and increased specialisation elevated the secondaries market to new heights in 2025.
Public markets: After years of private market growth, public markets may gain groundThanks to the evolution of a robust private market ecosystem that includes private credit, secondaries and unprecedented amounts of capital, companies are growing bigger and staying private for longer than ever before. Nevertheless, the dream to go public is still very much alive.
How private equity could reshape Latin AmericaPE has a major role to play in the region’s future, with regulatory changes and increased pension plan investment leading the charge.
Seven deals signal PE’s rising appetite for patient engagement platformsPrivate equity is zeroing in on healthtech investments that focus on technology-driven patient support.
CAZ expands access to GP stakes in iCapital tie-upUsers of iCapital's platform will be able to access CAZ's GP stakes offerings with a $100,000 minimum investment, a spokesperson tells PEI.
Eight biggest healthcare PE stories over the last 12 monthsThe past 12 months have seen plenty of private markets action in the healthcare sector, even as the regulatory environment gets tougher.
Meet the LP: CAZ InvestmentsBacked by family office capital at inception in 2001, Texas-based CAZ has become one of the largest allocators to GP stakes funds and directs over the past two decades.